Sujla Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 20-05-2024
- Paid Up Capital ₹ 0.10 M
as on 20-05-2024
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 11.11%
(FY 2020)
- Profit 172.55%
(FY 2020)
- Ebitda -8.49%
(FY 2020)
- Net Worth 1.57%
(FY 2020)
- Total Assets 1.85%
(FY 2020)
About Sujla Bio-Tech
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prabhat Kumar and Pritam Sahu serve as directors at the Company.
- CIN/LLPIN
U74999WB2009PTC136949
- Company No.
136949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sujla Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhat Kumar  | Director | 24-Mar-2021 | Current |
| Pritam Sahu | Director | 24-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Sujla Bio-Tech.
Sujla Bio-Tech Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.11% increase. The company also saw a substantial improvement in profitability, with a 172.55% increase in profit. The company's net worth moved up by a moderate rise of 1.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sujla Bio-Tech?
In 2016, Sujla Bio-Tech had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Exclusive Sarees Private LimitedActive 15 years 5 monthsPrabhat Kumar and Pritam Sahu are mutual person
- Bramcharni Sales Private LimitedActive 15 years 10 months
Prabhat Kumar and Pritam Sahu are mutual person
- Skandamata Dealers Private LimitedActive 15 years 10 months
Prabhat Kumar and Pritam Sahu are mutual person
- Popular Vinimay Private LimitedActive 16 years 3 months
Prabhat Kumar and Pritam Sahu are mutual person
- Ramnik Agency Private LimitedActive 17 years 2 months
Prabhat Kumar and Pritam Sahu are mutual person
- Mansamata Distributors Private LimitedActive 16 years 2 months
Prabhat Kumar and Pritam Sahu are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sujla Bio-Tech?
Unlock and access historical data on people associated with Sujla Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sujla Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sujla Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
